ACTRN12622001339741: A First-in-Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients With Advanced Tumors |
|
|
| Recruiting | 1 | 36 | | | Tigermed Australia Pty Ltd, Taizhou Haihe Pharmaceutical Co.,Ltd. | Solid Tumors, relapsed/refractory Non-Hodgkin’s lymphomas (NHL) | | | | |